TFPI Antikörper (C-Term)
Kurzübersicht für TFPI Antikörper (C-Term) (ABIN374077)
Target
Alle TFPI Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- C-VKIAYEEIFV KNM
-
Spezifität
- This antibody is expected to recognize isoform a (NP_006278.1) only.
-
Aufreinigung
- Affinity Chromatography
-
Immunogen
- Peptide sequence corresponding to the C-terminus of TFPI (NP_006278.1). Genename: TFPI
-
-
-
-
Applikationshinweise
-
Peptide ELISA: 1/64000. Western blot: 0.3 - 1 μg/mL. Approx 50 kDa band observed in lysates of cell lines HepG2 andHeLa (calculated MW of 35.0 kDa according to NP_006278.1).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- TRIS buffered saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- TFPI (Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor) (TFPI))
-
Andere Bezeichnung
- TFPI
-
Hintergrund
- TFPI is a protease inhibitor that helps to maintain haemostasis by inhibiting factor Xa and the Factor VIIa/Tissue factor (TF) complex. TFPI is also reported to associate with lipoproteins in plasma.Synonyms: EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein-associated coagulation inhibitor, TFPI1, Tissue factor pathway inhibitor
-
Gen-ID
- 7035
-
NCBI Accession
- NP_006278
-
UniProt
- P10646
Target
-